Azora Therapeutics, Inc. (AZR)

NASDAQ

$3.94

$-0.10

(-2.60%)

Regular Market

Azora Therapeutics, Inc. (AZR) Live Price Chart

Last updated: ⁦2026-11-05 16:57:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Azora Therapeutics, Inc. (AZR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.94, with a market capitalization of $10.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.02 to $4.97. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.90M
Open	$4.04
Day's High	$54.42
Day's Low	$3.02
Previous Close	$4.05
Volume	5.34K
Average Volume	79.97K
P/E Ratio	--
52-Week High	$4.97
52-Week Low	$3.02
Dividend Yield	--
Earnings Date	--

Azora Therapeutics, Inc. (AZR) Stock Price Today

Azora Therapeutics, Inc. (AZR) is currently trading at $3.94 as of 2026-11-05 16:44:00, down 2.84% ($0.11) from the previous close of $4.05

During today's regular trading session, AZR has traded between $3.02 and $54.42, with a trading volume of 5.34K shares. The current price is near the lower end of today's range.

Azora Therapeutics, Inc. (AZR) 7-Day Stock Price Change

Over the past seven days, Azora Therapeutics, Inc. (AZR) moved from $4.88 to $3.94, representing a decline of 19.36% ($0.94).

The stock traded between $3.02 and $4.97 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 79.97 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.

AZR 52-Week Price Position

Position in Range: 46.9%

52W Low$3.02

52W High$4.97

AZR is currently trading at $3.94, placing it 46.9% of the way from its 52-week low of $3.02 to its 52-week high of $4.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Azora Therapeutics, Inc. (AZR)?

Azora Therapeutics Inc is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. Azora owns the royalty-free rights to its technology, which is based on the development of potential best-in-class oral agonists of the aryl hydrocarbon receptor. Azora's lead program is AT177, a proprietary colon-targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure in development for ulcerative colitis.

Azora Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	6
Exchange	NASDAQ
Company Website	https://www.azoratherapeutics.com

How to Buy Azora Therapeutics, Inc. (AZR) Stock on MEXC

Eligible investors can buy real shares of Azora Therapeutics, Inc. (AZR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AZR and Place Your Order

Open the RealStocks trading page and search for AZR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Azora Therapeutics, Inc. (AZR) stock price today?

Azora Therapeutics, Inc. (AZR) is currently trading at $ 3.94, down 2.84% ($0.11) from the previous close of $ 4.05. Intraday prices update in real time during regular trading hours.

2.Is AZR stock going up or down today?

As of 2026-11-05 16:44:00, AZR is trading at $ 3.94, down 2.84% ($0.11) from its previous close of $ 4.05. The stock has traded between $ 3.02 and $ 54.42 during today’s regular session. Past price movements do not guarantee future results.

3.What is AZR pre-market price?

As of 2026-11-05 16:44:00, AZR is trading at $ 4.06 in pre-market trading, up 0.12% ($0.00) from the previous close of $ 4.05. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AZR after-hours price?

As of 2026-11-05 16:44:00, AZR is trading at $ 3.98 in after-hours trading, down 1.83% ($0.07) from the regular-session close of $ 4.05. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AZR stock trading now?

AZR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AZR sit relative to its 52-week high and low?

Over the past 52 weeks, AZR has traded between a low of $ 3.02 and a high of $ 4.97. At $ 3.94, the stock is positioned 46.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Azora Therapeutics, Inc. in?

Azora Therapeutics, Inc. (AZR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Azora Therapeutics, Inc.'s market capitalization and where is it listed?

Azora Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 10.90M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AZR valued in terms of P/E ratio and EPS?

AZR trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Azora Therapeutics, Inc. pay a dividend?

Azora Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.